Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 13, Number 5, May 2002   [Index by Author] 
Other Issues: Previous Next  

Down News
Down Editorials
Down Reviews
Down Breast cancer
Down Gastrointestinal tumors
Down Lung cancer
Down Phase I and pharmacokinetics
Down Miscellaneous tumors
Down Hematologic Malignancies
Down Clinical cases
Down Letters to the Editor
Down Book reviews


[Search ALL Issues]


To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

News Back

WHO and six publishers launch Access to Research, internet initiative for developing countries
Ann Oncol 2002 13: 641-645; doi:10.1093/annonc/mdf233 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

Editorials Back

T. M. Suter and B. Meier
Detection of anthracycline-induced cardiotoxicity: is there light at the end of the tunnel?
Ann Oncol 2002 13: 647-649; doi:10.1093/annonc/mdf231 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

L. Gianni
High-dose chemotherapy for breast cancer: any use for it?
Ann Oncol 2002 13: 650-652; doi:10.1093/annonc/mdf232 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

Reviews Back

M. Hejna, M. Schmidinger, and M. Raderer
The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?
Ann Oncol 2002 13: 653-668; doi:10.1093/annonc/mdf142 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

G. Davies, L.-A. Martin, N. Sacks, and M. Dowsett
Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention
Ann Oncol 2002 13: 669-678; doi:10.1093/annonc/mdf125 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Breast cancer Back

A. Schneeweiss, M. Hensel, P. Sinn, T. Khbeis, R. Haas, G. Bastert, and A. D. Ho
Characteristics associated with long-term progression-free survival following high-dose chemotherapy in metastatic breast cancer and influence of chemotherapy dose
Ann Oncol 2002 13: 679-688; doi:10.1093/annonc/mdf168 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

J. G. Schrama, I. F. Faneyte, J. H. Schornagel, J. W. Baars, J. L. Peterse, M. J. van de Vijver, O. Dalesio, H. van Tinteren, E. J. T. Rutgers, D. J. Richel, and S. Rodenhuis
Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-up
Ann Oncol 2002 13: 689-698; doi:10.1093/annonc/mdf203 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

B. V. Jensen, T. Skovsgaard, and S. L. Nielsen
Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients
Ann Oncol 2002 13: 699-709; doi:10.1093/annonc/mdf132 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

D. Cardinale, M. T. Sandri, A. Martinoni, E. Borghini, M. Civelli, G. Lamantia, S. Cinieri, G. Martinelli, C. Fiorentini, and C. M. Cipolla
Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy
Ann Oncol 2002 13: 710-715; doi:10.1093/annonc/mdf170 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Gastrointestinal tumors Back

S. Cascinu, F. Graziano, F. Ferraù, V. Catalano, C. Massacesi, D. Santini, R. R. Silva, S. Barni, A. Zaniboni, N. Battelli, S. Siena, P. Giordani, D. Mari, A. M. Baldelli, S. Antognoli, R. Maisano, D. Priolo, M. A. Pessi, G. Tonini, S. Rota, and R. Labianca
Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD)
Ann Oncol 2002 13: 716-720; doi:10.1093/annonc/mdf091 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

T. Conroy, P.-L. Etienne, A. Adenis, M. Ducreux, B. Paillot, J. Oliveira, J.-F. Seitz, E. Francois, E. Van Cutsem, D. J. T. Wagener, F. Kohser, S. Daamen, M. Praet, T. Gorlia, B. Baron, and J. Wils
Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival
Ann Oncol 2002 13: 721-729; doi:10.1093/annonc/mdf063 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

J. Feliu, J. Calvillo, A. Escribano, J. de Castro, M. E. Sánchez, A. Mata, E. Espinosa, A. García Grande, A. Mateo, and M. González Barón
Neoadjuvant therapy of rectal carcinoma with UFT–leucovorin plus radiotherapy
Ann Oncol 2002 13: 730-736; doi:10.1093/annonc/mdf116 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Lung cancer Back

S. J. Clarke, R. Abratt, L. Goedhals, M. J. Boyer, M. J. Millward, and S. P. Ackland
Phase II trial of pemetrexed disodium (ALIMTA®, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer
Ann Oncol 2002 13: 737-741; doi:10.1093/annonc/mdf115 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

M. Pérol, H. Léna, P. Thomas, G. Robinet, P. Fournel, E Coste, C. Belleguic, H. Le Caer, F. Blanchon, A. Vergnenègre, J.-M Vernejoux, M.-P. Schuller-Lebeau, and E. Pham
Phase II randomized multicenter study evaluating a treatment regimen alternating docetaxel and cisplatin–vinorelbine with a cisplatin–vinorelbine control group in patients with stage IV non-small-cell lung cancer: GFPC 97.01 study
Ann Oncol 2002 13: 742-747; doi:10.1093/annonc/mdf128 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

R. Arriagada, T. Le Chevalier, A. Rivière, P. Chomy, I. Monnet, E. Bardet, J. A Santos-Miranda, C. Le Péchoux, M. Tarayre, S. Benhamou, and A. Laplanche
Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients
Ann Oncol 2002 13: 748-754; doi:10.1093/annonc/mdf123 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Phase I and pharmacokinetics Back

F. Mayer, J. T. Hartmann, J. von Pawel, J. Beck, M. Schroeder, I. Boehlke, L. Kanz, and C. Bokemeyer
A phase I study of oral uracil–ftorafur plus folinic acid in combination with weekly paclitaxel in patients with solid tumors
Ann Oncol 2002 13: 755-759; doi:10.1093/annonc/mdf129 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

E. Cellarier, C. Terret, P. Labarre, R. Ouabdesselam, H. Curé, C. Marchenay, J. C. Maurizis, J. C. Madelmont, P. Chollet, and J. P. Armand
Pharmacokinetic study of cystemustine, administered on a weekly schedule in cancer patients
Ann Oncol 2002 13: 760-769; doi:10.1093/annonc/mdf098 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

M. A. Rosenthal, D. Rischin, G. McArthur, K. Ribbons, B. Chong, J. Fareed, G. Toner, M. D. Green, and R. L. Basser
Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia
Ann Oncol 2002 13: 770-776; doi:10.1093/annonc/mdf117 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Miscellaneous tumors Back

C. Twelves, M. Campone, B. Coudert, M. Van den Bent, M. de Jonge, C. Dittrich, R. Rampling, R. Sorio, D. Lacombe, C. de Balincourt, and P. Fumoleau
Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme
Ann Oncol 2002 13: 777-780; doi:10.1093/annonc/mdf121 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Hematologic Malignancies Back

W.-I. Lee, H. Kantarjian, A. Glassman, M. Talpaz, and M.-S. Lee
Quantitative measurement of BCR/abl transcripts using real-time polymerase chain reaction
Ann Oncol 2002 13: 781-788; doi:10.1093/annonc/mdf156 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

C. Patte, C. Sakiroglu, S. Ansoborlo, A. Baruchel, E. Plouvier, H. Pacquement, and A. Babin-Boilletot
Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d’Oncologie Pédiatrique LMB89 protocol
Ann Oncol 2002 13: 789-795; doi:10.1093/annonc/mdf134 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Clinical cases Back

N. Frickhofen, F.-J. Beck, B. Jung, H.-G. Fuhr, H. Andrasch, and M. Sigmund
Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil
Ann Oncol 2002 13: 797-801; doi:10.1093/annonc/mdf035 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

A. Trojan, M. Jermann, C. Taverna, and T. F. Hany
Fusion PET–CT imaging of neurolymphomatosis
Ann Oncol 2002 13: 802-805; doi:10.1093/annonc/mdf057 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Letters to the Editor Back

J. Rudi
Chemotherapy with gemcitabine in patients with gall-bladder carcinoma
Ann Oncol 2002 13: 807; doi:10.1093/annonc/mdf162 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

V. Medina Arana, Y. Barrios del Pino, C. García-Castro, J. J. González-Aguilera, A. Fernández-Peralta, and F. González Hermoso
Highly aggressive leiomyosarcoma associated with Lynch II syndrome: increasing the range of extracolonic cancers related with hereditary non-polyposis colonic cancer
Ann Oncol 2002 13: 807-808; doi:10.1093/annonc/mdf163 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

Book reviews Back

D. Schrijvers
D. Jeffrey (ed). Teaching Palliative Care: A Practical Guide
Ann Oncol 2002 13: 809; doi:10.1093/annonc/mdf141 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

D. Fink
S.C. Rubin, G.P. Sutton (eds).Ovarian Cancer
Ann Oncol 2002 13: 809-810; doi:10.1093/annonc/mdf140 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

M. Bendandi
S.A. Brooks, U. Schumacher (eds). Metastasis Research Protocols, Volumes 1 & 2
Ann Oncol 2002 13: 810; doi:10.1093/annonc/mdf180 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.